Concord Healthcare Grp Co (2453.HK) Q1 2025 Earnings Report

Concord Healthcare Grp Co Ltd reported QQ1 2025 revenue of 100,451,500 CNY, marking a QoQ increase of 18.65% after a challenging prior quarter, while yoy growth stood at -8.35%. The quarter showed a meaningful margin inflection: gross profit turned positive at 191,500 CNY and gross margin improved to approximately 0.19%, a significant swing from Q4 2024’s gross loss. Despite this improvement, the company remains unprofitable at the bottom line, posting an operating loss of 60,180,000 CNY and a net loss of 88,299,000 CNY for the quarter. EBITDA remained negative at 26,432,500 CNY, with an EBITDAR of -26.31%. The depreciation and amortization burden (32,822,500 CNY) continues to weigh on profitability, underscoring a cost base that must be scaled or reined in to convert near-term top-line strength into durable earnings power.